Troy– Author –
-
Silicon Box Secures $77.5M to Scale Advanced Packaging and Chiplet Integration
DealStreetAsia Singapore Overview Singapore-based semiconductor packaging and chiplet integration startup, Silicon Box, has secured S$100 million (approximately US$77.5 million) in debt financing from a global consortium of institutional... -
Samsung to Establish Gwangju Advanced Packaging Facility, Eyes Full HBM Hybrid Bonding Transition by 2029
TrendForce South Korea Overview Samsung Electronics is reportedly considering a new advanced semiconductor packaging plant in Gwangju, South Korea, with investment plans potentially announced by June 2026. This strategic facility will fo... -
SK Hynix Boosts HBM4 Production with Major TC Bonder Order from Hanmi Semiconductor
The Korea Herald South Korea Overview SK Hynix has made a significant investment, ordering ₩44.2 billion (approx. $28.7 million USD) worth of advanced 'TC Bonder 4.5 Griffin' thermo-compression bonders from Hanmi Semiconductor. This stra... -
TSMC to Boost CoWoS Capacity Tenfold to 130K Wafers/Month by Late 2026, Accelerates Glass-Substrate CoPoS for AI Chips
Tom's Hardware USA Overview TSMC is aggressively expanding its advanced packaging capacity, projecting a tenfold increase in CoWoS production to over 130,000 wafers per month by the end of 2026 to meet surging AI demand. Despite this, de... -
Reliability of AI Antibody Design Hinges on Training Data: AlphaFold Era Highlights Data Quality Challenge
Drug Discovery News USA Overview Advancements in protein AI, such as AlphaFold, have ushered in a new computational era for antibody discovery, enabling predictions of protein folding and interactions with near-experimental accuracy. How... -
FDA Streamlines Nonclinical Studies for Biologics and Conjugated Products, Accepting NAMs for ADCs to Reduce Non-Human Primate Use
FDA USA Overview The FDA's Center for Drug Evaluation and Research (CDER) is streamlining nonclinical studies for biologics and conjugated products, including Antibody-Drug Conjugates (ADCs) and CD3 bispecific T-cell engagers. For ADCs w... -
Imperial College London’s DeCAF-Pearl AI Model Enables Practical Large-Scale Molecular Screening, Surpassing AlphaFold 3 Efficiency
Imperial College London UK Overview Researchers at Imperial College London, in collaboration with the Genesis Research Team, have developed DeCAF-Pearl, a new AI model based on flow maps that makes large-scale molecular screening practic... -
UVA’s YuelDesign AI Framework Models Protein Flexibility for Improved Drug Design, Demonstrating Success on CDK2 Target
IntuitionLabs USA Overview The YuelDesign framework, developed by a UVA team, represents a significant advancement in structure-based drug design by explicitly modeling protein flexibility during ligand generation using AI diffusion mode... -
Latent Labs’ Generative AI Transforms Molecular Design, Producing Macrocyclic Peptides and Antibody Candidates in Weeks
CVPR (Computer Vision and Pattern Recognition) USA Overview Latent Labs, through its Latent-X1 and Latent-Y platforms, is transforming drug discovery by enabling de novo molecular design from intent, rather than traditional library scree... -
ThinkBio.Ai Leads AI Drug Discovery Tools Market, Innovating Target Identification and Clinical Trial Planning
BioStock Info スウェーデン Overview AI is generating significant value across drug discovery by enhancing target identification, drug repurposing, and clinical trial planning. Platforms like ThinkBio.Ai, Schrödinger, and Insilico Medicin...
